In lung adenocarcinomas (n = 515), the most frequently mutated genes were TP53 (n = 233), CDKN2A (n = 109), KRAS (n = 95), CDKN2B (n = 91), and EGFR (n = 82). This evidence concerns the gene CDKN2A and lung adenocarcinoma.